Melatonin benefits: what is actually proven

Only two melatonin benefits are recognised in the European Union: it contributes to reducing the time needed to fall asleep, and it helps alleviate the subjective feeling of jet lag. Nothing else. If you have found lists with ten or fifteen effects — antioxidant, immunity, cardiovascular health, anti-ageing — you have found marketing, not regulation. The difference between those two sentences and all the others is not bureaucracy: it is the difference between an effect assessed by a scientific panel with access to the trials and an effect that someone wrote on a blog.

It is worth understanding why, because melatonin is a hormone with a clear physiological role. It is the main hormonal signal of the sleep-wake cycle, produced by the pineal gland mainly at night, and its secretion adjusts to the length of the night. That role is real. What is not automatic is that taking a supplement produces every effect that physiology suggests. Research explores several hypotheses; exploring is not the same as demonstrating in a clinical trial.

The two benefits authorised in the EU

The European list of health claims permitted for foods and supplements is closed. A claim either appears on it, with specific wording and conditions of use, or it cannot be made. For melatonin, two appear: reduction of the time needed to fall asleep, with at least 1 mg taken close to bedtime, and alleviation of the subjective feeling of jet lag, with at least 0.5 mg taken close to bedtime on the first day of travel and on the days following arrival.

Notice what the first sentence says and what it does not say: it speaks of the time to fall asleep, not sleep quality, not the number of awakenings, not waking up more rested. And notice the word “subjective” in the second: what was assessed is how the person feels, not an objective measure of the biological clock's adaptation. Two modest sentences — and they are the only ones.

What melatonin does not do, demonstrably

Melatonin has antioxidant activity in the laboratory, and there is research exploring roles in the immune system and in other areas. None of that has reached the point of generating an authorised claim, and presenting it as an established benefit would mislead the reader. Reviews of the literature on the properties of exogenous melatonin show exactly this: the effects described vary widely between studies and populations, and consistency is low.

There is also a common confusion worth clarifying: melatonin is not a sedative. It does not switch you off. What it does is signal to the body that it is night — it is a clock signal, not a light switch. That is why it tends to work when the problem is a misaligned clock, and works poorly when the problem is anxiety, pain, sleep apnoea or an impossible shift pattern.

What clinical trials actually show

The evidence on melatonin is not uniform, and the differences between populations are large. In a meta-analysis of 19 randomised placebo-controlled trials, which included 1683 adults and children with primary sleep disorders, melatonin reduced sleep latency by about 7 minutes on average and increased total sleep time by about 8 minutes; subjective sleep quality also improved, with a small effect. These are modest differences, measured in a trial context, and they do not mean everyone will feel the same.

A more recent meta-analysis, of 24 randomised trials in people with chronic insomnia, gave a more nuanced picture: in adults without other associated conditions, melatonin was not significantly effective at improving sleep latency, total sleep time or sleep efficiency; in children and adolescents it was effective on those measures; in people with insomnia associated with another condition it improved sleep latency in all age groups, but based on only 22 studies in adults. In other words, the effect depends heavily on who is taking it and what kind of problem they have.

A meta-analysis of 23 randomised trials in adults with various illnesses found improvement in sleep quality measured by the PSQI index, with a mean difference of -1.24 points (95% CI -1.77 to -0.71), but with high heterogeneity between studies. And a meta-analysis of 31 trials of food supplements found improvement in subjective sleep quality with melatonin (mean difference -1.21; 95% CI -2.17 to -0.24), also with high heterogeneity.

A randomised, double-blind, placebo-controlled trial in 97 middle-aged adults with primary insomnia tested 3 mg of fast-release melatonin for four weeks, taken one hour before bedtime. Melatonin reduced early-morning wake time by about 30 minutes and the percentage of N2 sleep, but had no significant effect on sleep latency, sleep efficiency, night-time awakenings or the percentage of deep (N3) and REM sleep. This illustrates the variability well: the same supplement can show an effect on one measure and not another.

There is also a review that stresses that, despite the theoretical appeal of replacing the melatonin that declines with age, the evidence supporting that benefit is scarce, and the most appropriate doses and formulations remain to be clearly defined.

When it makes sense, and when it does not

The scenarios in which melatonin is most likely to help share one characteristic: the internal clock is out of phase with the time the person needs to sleep. The review on melatonin as a chronobiotic describes exactly this — the timing of the dose and the amount are decisive, and the effects vary between healthy people, people with circadian rhythm disorders and people with primary insomnia.

• Travel across several time zones, especially eastward.
• A pattern of falling asleep very late and waking very late, when life demands the opposite.
• One or two nights of readjustment after a period of irregular hours.

The scenarios in which it is rarely the right answer also share a characteristic: the clock is fine, and something else is blocking sleep.

• Insomnia that has lasted for months. It is a clinical condition with its own treatments, and the first of them is not a supplement.
• Waking several times during the night, or waking tired despite having slept enough hours.
• Loud snoring with pauses in breathing — a sign that deserves medical assessment, not a supplement.

If you fall into the second group, taking melatonin probably will not harm you. It probably will not solve anything either, and the time spent trying is time in which the real problem goes unanswered.

Timing matters more than quantity

This is the part almost everyone gets backwards. With melatonin, the time you take it matters more than how much you take. The effect depends on where your biological clock is at that moment: the same dose taken at 10pm and at 3am does not produce the same result — it may even push the clock in the opposite direction to the one you wanted. Taken consistently at the same time, close to bedtime, the signal is coherent; taken at random times, the signal is noise.

There is a second factor that is usually ignored: light. The body produces melatonin when it gets dark and stops producing it under bright light, especially blue light. Taking a supplement and then spending an hour with a phone a few centimetres from your eyes sends two contradictory signals to the same system. If you are going to make only one change, dimming the lights in the hour before bed competes on equal terms with any supplement.

As for quantity: the conditions attached to the European claims mention 1 mg for time to fall asleep and 0.5 mg for jet lag. These are regulatory thresholds, not a personalised recommendation. More is not better — at high doses you are more likely to feel residual drowsiness the next morning, which is precisely the opposite of the goal.

What the Sleep Well Gummies label says

Sleep Well Gummies by TuttiBear provide 1 mg of melatonin per serving of 2 gummies, in a tub of 60 gummies. The directions are for adults to chew 2 gummies per day, shortly before bedtime. The amount per serving corresponds to the 1 mg threshold associated with the claim on reducing the time needed to fall asleep.

The trials that used higher doses — such as the 3 mg in the trial with adults with primary insomnia — are not dosing instructions, and they do not show that this dose is necessary or preferable. Study doses are not personalised recommendations. The label also states that the product is not recommended for children, pregnant or breastfeeding women, that it may cause drowsiness and that you should avoid driving or operating machinery after taking it. It contains polyols and excessive consumption may produce laxative effects.

Children, pregnancy and medication

In children, the decision belongs to the paediatrician. The appropriate amount depends on age, weight, the cause of the difficulty in sleeping and what the child is already taking — and in children the cause is often behavioural or environmental, not hormonal. A recent systematic review on the use of melatonin in young children (0–6 years) found that melatonin is the leading cause of unsupervised medicine exposure and overdose in emergency departments in this age group, and that long-term safety and efficacy data are limited. We do not give a number here because a number given without that context is, at best, useless.

In pregnancy and breastfeeding, there is not enough basis to recommend use. Talk to your doctor or pharmacist before taking it. If you take regular medication — anticoagulants, antiepileptics, antidiabetics, immunosuppressants, hormonal contraceptives — check with a healthcare professional before adding melatonin. This is not a formality: some interactions are real.

If you are thinking of taking melatonin every day, or have doubts about side effects and duration, it is worth reading up before deciding. And if your question is a paediatrician's decision for a child, that is a separate conversation to have with the paediatrician.

If you took it and noticed no difference

It happens, and it does not necessarily mean the product is bad. Before increasing the dose, it is worth checking three things. The first is timing: if you took it already in bed, with sleep still not arriving an hour later, you took it too late for the signal to have an effect that night. The second is consistency: one night is not a test. The third is diagnosis: if what keeps you awake is worry, pain, late-afternoon caffeine or a room that is too warm, melatonin solves none of that.

And if, after correcting the timing and the environment, your sleep is still poor for weeks, the next step is an appointment, not a higher dose. Persistent insomnia has treatments with much better evidence than any supplement — including cognitive behavioural therapy for insomnia, which is the recommended first line and which most people have never heard mentioned.

The summary, without adornment

Melatonin is useful for a specific problem: a misaligned biological clock. For that problem it helps you fall asleep faster and softens jet lag, and those two effects are recognised. Outside that problem, it is a supplement that probably will not harm you and probably will not do anything for you. We prefer to say this rather than sell you a list of fifteen benefits.

If your case is the first, take it at the same time, close to bedtime, and dim the lights. If it is the second, the time you would spend comparing brands is better spent working out what is really ruining your nights.